Events & Presentations

Upcoming Events
Date Event Details Remind Me
Sep 26, 2023 10:30 AM EDT
2023 Cantor Fitzgerald Global Healthcare Conference
Archived Events
Date Event Details
Jun 13 - Jun 16, 2022
Goldman Sachs 43rd Annual Global Healthcare Conference
Type: Fireside chat presentation
Presenter: Vincent Anzalone, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals
Jun 8, 2022 8:30 AM EDT
Jefferies Healthcare Conference
Type: Fireside chat presentation
Presenter: Vincent Anzalone, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals
May 26, 2022 10:00 AM EDT
Pulmonary R&D Day
New York
May 25, 2022 12:15 PM EDT
UBS Global Healthcare Conference 2022
Type: Fireside chat presentation
Presenter: Vincent Anzalone, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals
May 17, 2022 4:35 PM EDT
2022 RBC Capital Markets Global Healthcare Conference
Type: Fireside chat presentation
Presenter: Christopher Anzalone, President and CEO, Arrowhead Pharmaceuticals
May 13 - May 18, 2022
2022 American Thoracic Society (ATS) International Conference
Title: Silencing RAGE Expression with a Lung-Targeted RNAi Trigger Delivery Platform Suppresses Pulmonary Allergic Inflammation
Presenter: David Kasahara, Senior Scientist III, Biology, Arrowhead Pharmaceuticals
    
Title: Silencing Muc5ac Expression with a Lung-Targeted RNAi Trigger Prevents Allergen-Induced Mucoobstruction and Airway Hyperresponsiveness
Presenter: David Kasahara, Senior Scientist III, Biology, Arrowhead Pharmaceuticals
 
May 12, 2022 1:40 PM EDT
BofA Securities 2022 Healthcare Conference
Type: Fireside chat presentation
Presenter: Christopher Anzalone, President and CEO, Arrowhead Pharmaceuticals
 
May 10, 2022 4:30 PM EDT
Arrowhead Pharmaceuticals 2022 Second Quarter Results
May 9 - May 12, 2022
TIDES USA 2022: Oligonucleotide and Peptide Therapeutics
Title: Arrowhead’s Approach to Oligonucleotide Scale-Up Manufacturing
Presenter: Michael Lawler, Director, Chemistry, Arrowhead Pharmaceuticals
 
Apr 25 - Apr 27, 2022
DIA/FDA's Oligonucleotide-based Therapeutics Conference (Oligo22)

Title: Short Interfering RNA JNJ-3989 Combination Therapy
Presenter: Michael Biermer, Senior Director, Clinical Development, Janssen Pharmaceuticals

Title: ARO-HIF2 Evaluated in Clear Cell Renal Cell Carcinoma Ph1b Clinical Trial
Presenter: James Hamilton, Senior Vice President, Discovery and Translational Medicine, Arrowhead Pharmaceuticals